STING1 and tuberculosis: In support of this hypothesis, a previous study from our group showed that overexpression of the small-molecule STING agonist cyclic di-AMP could be delivered intracellularly using BCG as a vehicle, leading to substantially augmented BCG-induced anti-TB immunity in the guinea pig model (84).